Brief: Proqr Prices $50.0 Million Underwritten Registered Direct Offering And Concurrent Private Placement
BRIEF-Proqr Prices $50.0 Million Underwritten Registered Direct Offering And Concurrent Private Placement June 25 (Reuters) - ProQR Therapeutics NV PRQR.O:
PROQR PRICES $50.0 MILLION UNDERWRITTEN REGISTERED DIRECT OFFERING AND CONCURRENT PRIVATE PLACEMENT
PROQR THERAPEUTICS NV - ELI LILLY TO PURCHASE 5.1 MILLION PROQR SHARES AT $1.81/SHARE FOR $9.2 MILLION
PROQR THERAPEUTICS NV - TO USE PROCEEDS FOR RESEARCH, CLINICAL DEVELOPMENT, AND GENERAL CORPORATE PURPOSES
Source text: ID:nGNX5vSLsz
Further company coverage: PRQR.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on ProQR Therapeutics NV
See all newsProQR Therapeutics NV reports results for the quarter ended June 30 - Earnings Summary
ProQR Q2 revenue more than doubles
Brief: ProQR Therapeutics Q2 EPS EUR -0.08
ProQR Therapeutics NV expected to post a loss of 11 cents a share - Earnings Preview
ProQR Therapeutics NV expected to post a loss of 11 cents a share - Earnings Preview